Cite
HARVARD Citation
Park, B. et al. (2019). A phase II trial of bendamustine, carboplatin, and dexamethasone for refractory or relapsed peripheral T-cell lymphoma (BENCART trial). Leukemia & lymphoma. 60 (13), pp. 3251-3257. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Park, B. et al. (2019). A phase II trial of bendamustine, carboplatin, and dexamethasone for refractory or relapsed peripheral T-cell lymphoma (BENCART trial). Leukemia & lymphoma. 60 (13), pp. 3251-3257. [Online].